Please assess the completion status of the following clinical trial:

Trial Title: Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subjects with asthma as determined by ICD-9 codes and asthma drug use~* at least 65 years of age~* prescription for an inhaled corticosteroid~Exclusion Criteria:~* a diagnosis of chronic obstructive pulmonary disease or~* a prescription for a chronic obstructive pulmonary disease treatment

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Medicare-eligible subjects with asthma (Type: None): Asthma subjects at least 65 years of age enrolled in a large Medicare managed care health plan.

Based on this trial design, predict the completion outcome and termination type (if applicable).